Positive Phase 1 Trial Data in Non-Muscle Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress; ...

Clene planning to submit a New Drug Application (NDA) in the second half of 2025 for potential Accelerated Approval of CNM-Au8® in ALSClene ...

Discover how AI-driven crypto agents are evolving beyond ICO-style hype, moving toward sustainable value, revenue generation ...

The UK paved the way for global vaccine development during the Covid pandemic, with the Oxford-AstraZeneca vaccine – a collaboration between researchers at the University of Oxford and the ...

Use of DYNE-101 is leading to improvements in muscle, and specifically finger, function in myotonic dystrophy type 1 patients ...